Multi‐planner validation of RapidPlan knowledge‐based model for volumetric modulated arc therapy in prostate cancer

Abstract

AbstractPurposeTo investigate the performance of a model‐based optimization process for volumetric modulated arc therapy (VMAT) applied to prostate cancer patients with the multi‐planner.Methods and MaterialsThe 120 prostate plans for VMAT treatment were entered into the database system of the RapidPlan (RP) knowledge‐based treatment planning. The treatment planning data for each plan was used to create and train the RP model. Twelve prostate cancer cases were selected and were used for planning by a manual of 12 planners based on the clinical protocol for dose constraints. Then, the treatment plans for each patient were compared with the RP model plans and analyzed with Wilcoxon tests.ResultsOn average, the RP models can estimate comparable doses among all planner plans and clinical plans for the PTV, which Dmax, D95%, D98%, HI, and CI were used to evaluate. For the normal organ doses of the bladder, rectum, penile bulb, and femoral head, all RP model plans showed comparable or better dose sparing than all planner plans and clinical plans. Moreover, the average planning time of the RP model was faster than manual plans by about two times. The RP model can significantly reduce the variation dose of the normal organs compared with the manual plans among the planners.ConclusionThe automated plans of the RP model might benefit from further fine‐tuning of the dose constraints of the normal organs, although both procedure plans are acceptable and fulfill the clinical protocol goals so that the RP model can enhance the efficacy and quality of plans.